Skip to main content

Table 4 Average Daily Weight gain improvement/reduction between treatment groups over the finishing period and overall (* p = 0.0004 **p = 0.0014)

From: A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine

Compared groups

ADWG over the finishing period (g/d)

Reduction of ADWG over the finishing period

Wean-to-finish ADWG (g/d)

Reduction of ADWG from wean-to-finish

PCVM vs. NC

PCVM: 842

−38 g/day* and 95% CI [−57, −19]

PCVM: 660

−24 g/day** and 95% CI [−37, −11]

NC: 803

NC: 634

FLEX vs. NC

FLEX: 827

−26 g/day* and 95% CI [−44, −7]

FLEX: 650

−17 g/day** and 95% CI [−30, −3]

NC: 803

NC: 634

PCVM vs. FLEX

PCVM: 842

−12 g/day and 95% CI [−31, 7]

PCVM: 660

−8 g/day and 95% CI [−21, 6]

FLEX: 827

FLEX: 650